Literature DB >> 15030764

A twist code determines the onset of osteoblast differentiation.

Peter Bialek1, Britt Kern, Xiangli Yang, Marijke Schrock, Drazen Sosic, Nancy Hong, Hua Wu, Kai Yu, David M Ornitz, Eric N Olson, Monica J Justice, Gerard Karsenty.   

Abstract

Runx2 is necessary and sufficient for osteoblast differentiation, yet its expression precedes the appearance of osteoblasts by 4 days. Here we show that Twist proteins transiently inhibit Runx2 function during skeletogenesis. Twist-1 and -2 are expressed in Runx2-expressing cells throughout the skeleton early during development, and osteoblast-specific gene expression occurs only after their expression decreases. Double heterozygotes for Twist-1 and Runx2 deletion have none of the skull abnormalities observed in Runx2(+/-) mice, a Twist-2 null background rescues the clavicle phenotype of Runx2(+/-) mice, and Twist-1 or -2 deficiency leads to premature osteoblast differentiation. Furthermore, Twist-1 overexpression inhibits osteoblast differentiation without affecting Runx2 expression. Twist proteins' antiosteogenic function is mediated by a novel domain, the Twist box, which interacts with the Runx2 DNA binding domain to inhibit its function. In vivo mutagenesis confirms the antiosteogenic function of the Twist box. Thus, relief of inhibition by Twist proteins is a mandatory event precluding osteoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15030764     DOI: 10.1016/s1534-5807(04)00058-9

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  262 in total

1.  N-terminal truncations of human bHLH transcription factor Twist1 leads to the formation of aggresomes.

Authors:  Gokulapriya Govindarajalu; Murugan Selvam; Elango Palchamy; Sudhakar Baluchamy
Journal:  Mol Cell Biochem       Date:  2017-08-04       Impact factor: 3.396

2.  Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity.

Authors:  Chunxi Ge; Qian Yang; Guisheng Zhao; Hong Yu; Keith L Kirkwood; Renny T Franceschi
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741

Review 3.  Building strong bones: molecular regulation of the osteoblast lineage.

Authors:  Fanxin Long
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-22       Impact factor: 94.444

4.  Basic helix-loop-helix transcription factor Twist1 inhibits transactivator function of master chondrogenic regulator Sox9.

Authors:  Shoujun Gu; Thomas G Boyer; Michael C Naski
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

Review 5.  The skeletal subsystem as an integrative physiology paradigm.

Authors:  Aaron J Weiss; Jameel Iqbal; Neeha Zaidi; Jeffrey I Mechanick
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

6.  Jagged1 functions downstream of Twist1 in the specification of the coronal suture and the formation of a boundary between osteogenic and non-osteogenic cells.

Authors:  Hai-Yun Yen; Man-Chun Ting; Robert E Maxson
Journal:  Dev Biol       Date:  2010-08-19       Impact factor: 3.582

7.  c-Jun N-Terminal Kinases (JNKs) Are Critical Mediators of Osteoblast Activity In Vivo.

Authors:  Ren Xu; Chao Zhang; Dong Yeon Shin; Jung-Min Kim; Sarfaraz Lalani; Na Li; Yeon-Suk Yang; Yifang Liu; Mark Eiseman; Roger J Davis; Jae-Hyuck Shim; Matthew B Greenblatt
Journal:  J Bone Miner Res       Date:  2017-09       Impact factor: 6.741

Review 8.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

Review 9.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

10.  Regulation of neural crest cell fate by the retinoic acid and Pparg signalling pathways.

Authors:  Nan Li; Robert N Kelsh; Peter Croucher; Henry H Roehl
Journal:  Development       Date:  2010-02       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.